Clinical Trials Logo
  1. Home
  2. Vulvar Lichen Sclerosus
  3. NCT03926299

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus Clinical Trial

Official title:
Prospective, Randomized, Active-controlled Investigator Initiated Clinical Trial to Demonstrate That the Nd:YAG/Er:YAG Dual Laser Therapy is Effective to Treat Vulvar Lichen Sclerosus and Similar to Standard Treatment With Steroid Cream

Clinical Trial Summary

The aim of this study is to test a new, minimally invasive dual laser technique to treat vulvar lichen sclerosus. Efficacy and safety of the thermal non-ablative Nd:YAG laser and the ablative Er:YAG laser is determined and compared to the current standard treatment with high dose steroids. The hypothesis is that laser therapy is effective and similar to standard steroid therapy.

Clinical Trial Description

Lichen sclerosus (LS) is a chronic inflammatory skin disease that usually involves the anogenital area where it causes itching and burning pain, pain during sexual intercourse, and anal or genital bleeding due to fissuring of the damaged tissue. In this study a treatment with dual laser application combining thermal non-ablative Nd:YAG with ablative Er:YAG laser is used to reduce the symptoms of LS. Results will be compared to the standard therapy with topical steroid cream. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03926299
Study type Interventional
Source Cantonal Hospital, Frauenfeld
Contact
Status Active, not recruiting
Phase N/A
Start date July 15, 2019
Completion date July 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03961126 - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma. Phase 2
Completed NCT03686800 - The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients N/A
Completed NCT05147129 - Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Completed NCT02573883 - Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus Phase 3
Recruiting NCT06132919 - Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) Phase 2
Completed NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Terminated NCT01126255 - Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus Phase 2
Recruiting NCT04951206 - Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus Phase 4
Recruiting NCT05250466 - A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia N/A
Completed NCT04148651 - The CO2RE® System for Vulvar Lichen Sclerosus N/A
Completed NCT02416531 - Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser N/A
Recruiting NCT04967170 - A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus Phase 1/Phase 2
Terminated NCT04134494 - Laser Treatment for Vulvar Lichen Sclerosus N/A
Completed NCT05251220 - Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Completed NCT01400022 - Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus N/A
Recruiting NCT06360705 - StrataMGT for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT00757874 - Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus Phase 2
Recruiting NCT05243563 - Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? Phase 2/Phase 3